Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B cell lymphoma
|
|
- Bryce Welch
- 6 years ago
- Views:
Transcription
1 264 Assocition between LAPTM4B gene polymorphism nd susceptibility to nd prognosis of diffuse lrge B cell lymphom HUIRONG DING 1*, XIAOJING CHENG 2*, NING DING 3*, ZHIHUA TIAN 1, JUN ZHU 3, CHUNLIAN ZHOU 4, JING SHEN 1 nd YUQIN SONG 3 1 Centrl Lbortory; 2 Division of Gstrointestinl Cncer Trnsltionl Reserch Lbortory, Key Lbortory of Crcinogenesis nd Trnsltionl Reserch (Ministry of Eduction/Beijing); 3 Deprtment of Lymphom, Peking University Cncer Hospitl nd Institute; 4 Deprtment of Nosocomil Infection Prevention nd Control, Beijing Friendship Hospitl, Cpitl Medicl University, Beijing , P.R. Chin Received Jnury 12, 2016; Accepted July 14, 2017 DOI: /ol Abstrct. Lysosoml protein trnsmembrne 4β (LAPTM4B) is n oncogene tht is overexpressed in number of vrious types of humn cncer. There re two known lleles of LAPTM4B: LAPTM4B*1 nd LAPTM4B*2. The present study ssessed the ssocition between LAPTM4B polymorphisms nd the susceptibility to diffuse lrge B cell lymphom (DLBCL) nd its prognosis. LAPTM4B genotypes were determined using polymerse chin rection nlysis in 164 DLBCL nd 350 helthy control cses. The ssocition between LAPTM4B polymorphisms nd the risk of DLBCL ws nlyzed using unconditionl logistic regression. Differences in ptient survivl were clculted using Kpln Meier nlysis. The present study indicted no significnt differences (P>0.05) in the frequency of LAPTM4B*2 lleles between DLBCL cses (26.5%) nd controls (24.1%). The risk of DLBCL ws slightly incresed in cses with the LAPTM4B*1/2 genotype [odds rtio (OR)=1.160; 95% confidence intervl (CI)= ] or the LAPTM4B*2/2 genotype (OR=1.446; 95% CI= ) compred with those with the LAPTM4B*1/1 genotype. There ws no significnt ssocition between the presence of the Correspondence to: Professor Jing Shen, Centrl Lbortory, Key Lbortory of Crcinogenesis nd Trnsltionl Reserch (Ministry of Eduction/Beijing), Peking University Cncer Hospitl nd Institute, Fucheng 52, Hidin, Beijing , P.R. Chin E mil: shenjing69@sin.com Professor Yuqin Song, Deprtment of Lymphom, Peking University Cncer Hospitl nd Institute, Fucheng 52, Hidin, Beijing , P.R. Chin E mil: songyuqin622@sin.com * Contributed eqully Key words: diffuse lrge B cell lymphom, lysosoml protein trnsmembrne 4β, polymorphism, susceptibility, prognosis LAPTM4B*2 llele nd overll survivl (OS) nd disese free survivl (DFS) in ptients with DLBCL (P=0.399 nd 0.520, respectively). However, there ws tendency for ptients with LAPTM4B*2 nd Interntionl Prognostic Index (IPI) score 3 5 to hve longer OS nd DFS (P=0.126 nd 0.109, respectively). These findings suggest tht genetic polymorphisms of LAPTM4B is not risk fctor for the development of DLBCL, but the LAPTM4B*2 llele my better prognostic indictor in ptients with IPI score 3 5 in DLBCL. Introduction Diffuse lrge B cell lymphom (DLBCL) is the most common subtype of non Hodgkin lymphom (NHL), constituting up to 40% of ll cses globlly (1). DLBCL is highly heterogeneous disese. The stndrd front line therpy for DLBCL, which includes rituximb plus cyclophosphmide, doxorubicin, vincristine nd prednisone (R CHOP), hs improved the survivl rte of DLBCL ptients (2). However, ~33% of DLBCL ptients hve relpsed or refrctory type of disese, which ws reported by Sehn et l (2) in the province of British Columbi in 2005, nd the moleculr mechnism underlying DLBCL development remins to be fully understood (2 4). Although certin indictors my ssist in predicting prognosis in ptients with DLBCL, including the Interntionl Prognostic Index (IPI) score, MYC proto oncogene, nd tumor loction (5 7), the development of novel biomrkers for estimting the efficcy of therpeutic strtegies nd prognosis is required. LAPTM4B exists s two lleles: LAPTM4B*1 with one 19 bp segment (GenBnk ccession no. AY219176) nd LAPTM4B*2 with two tndem repet segments (GenBnk ccession no. AY219177) in the 5' untrnslted region of exon 1 (8). Previous studies hve demonstrted tht LAPTM4B polymorphisms were ssocited with susceptibility to multiple types of cncer, including lung, brest, gstric, colon, ovrin nd primry liver cncer (9 16), which suggested tht LAPTM4B*2 my be ssocited with significntly incresed risk of developing these types of cncer. LAPTM4B*2 ws lso ssocited with poor prognosis in ptients with heptocellulr,
2 DING et l: LAPTM4B GENE POLYMORPHISM IN DIFFUSE LARGE B-CELL LYMPHOMA 265 lung or endometril cncer (17 19). To the best of our knowledge, no study hs previously reported on the ssocition between LAPTM4B polymorphisms nd clinicl dt on DLBCL. The present study evluted whether LAPTM4B polymorphisms were ssocited with the susceptibility to nd prognosis of DLBCL. Mterils nd methods Ptients nd control cses. A totl of 164 ptients with DLBCL were enrolled (for the overll survivl nlysis, 35 cses were not included becuse of loss to follow up or ccepting non first line therpy), which included 81 mles nd 83 femles, men ge yers, with 2 individuls belonging to the LAPTM4B*1/3 genotype. The dignosis of the ptients ws confirmed by the Deprtment of Pthology (Peking University Cncer Hospitl nd Institute, Beijing, Chin) ccording to the World Helth Orgniztion clssifiction. Finl dignosis of ll ptients ws confirmed by pthologicl ssessment t the Beijing Cncer Hospitl, Peking University School of Oncology (Beijing, Chin), nd ll cses were collected between June 2007 nd December The Ann Arbor stging clssifiction system were used to determine the stge of these ptients (20). The dt for the 350 helthy control cses were quoted from the dt of Cheng et l (12), which included 225 mles nd 125 femles, men ge yers. The clinicl reserch protocol of the present study ws pproved by the Institutionl Review Bord (Peking University Cncer Hospitl nd Institute). The present study ws pproved by the Reserch nd Ethics Committee of Peking University School of Oncology. Ech ptient enrolled in the present study provided written informed consent for prticiption. DNA extrction. Blood smples were obtined from ll ptients with DLBCL prior to genetic nlysis. Genomic DNA ws extrcted from peripherl blood mononucler cells using blood genomic DNA extrction kit ccording to the mnufcturer's protocol (BioTeke Corportion, Beijing, Chin). The genomic DNA ws subsequently dissolved in Tris EDTA buffer nd stored t 80 C. Polymerse chin rection (PCR) nlysis. The genomic DNA (30 ng/20 µl) ws mplified using GoTq DNA polymerse (Promeg Corportion, Mdison, WI, USA) nd primers forwrd, 5' GCC GAC TAG GGG ACT GGC GGA 3' nd reverse, 5' CGA GAG CTC CGA GCT TCT GCC 3' which correspond to the nd bp of LAPTM4B, respectively (8). GAPDH ws used s the positive internl control in the present study, with the following primers: Forwrd, 5' GTC TGC CCT AAT TAT CAG GTC CA 3' nd reverse, 5' CCT GGC TCC TGG CAT CTC T 3'. PCR rection conditions were set using thermo cycler (Gene Cycler ; Bio Rd Lbortories, Inc., Hercules, CA, USA) s follows: Denturtion t 94 C for 2 min, followed by 35 cycles t 94 C for 30 sec, t 65 C for 30 sec, nd t 72 C for 30 sec. The lst cycle ws followed by uto extension t 72 C for 7 min. The mplified products were subsequently nlyzed using electrophoresis on 10% polycrylmide or 2% grose gel. Visuliztion ws performed using GelRed (Biotium, Hywrd, CA, USA). All smples re repeted by two independent PCR nlysis. The DNA frgments were purified using the AxyPrep DNA Gel Extrction kit ccording to the mnufcturer's protocol (Axygen Scientific, Inc., Union City, CA, USA). The purified products were sequenced using n ABI 3730XL Avnt Genetic nlyzer (Applied Biosystems; Thermo Fisher Scientific, Inc., Wlthm, MA, USA), ccording the mnufcturer's protocol. The sequences were subsequently nlyzed using Seqmn softwre DNASTAR version 5.2 (DNASTAR Inc., Mdison, WI, USA). Sttisticl nlysis. Sttisticl nlysis ws performed using SPSS 16.0 softwre (SPSS, Inc., Chicgo, IL, USA). The χ 2 test or the Fisher's exct test ws used to clculte genotype frequency (including Hrdy Weinberg equilibrium) nd other clinicl prmetric distributions between DLBCL nd control cses. Unconditionl logistic regression nlysis models were used to ssess the ssocition, djusted by ge nd sex, between different genotypes nd cncer risks. The clinicl chrcteristics nd response rte of the ptients were compred using the χ 2 test or the Fisher's exct test ccording to the different genotypes. The ssocition between LAPTM4B gene polymorphism nd overll survivl (OS) nd disese free survivl (DFS) ws evluted using Kpln Meier curves nd the log rnk test. All sttisticl tests were two sided. P<0.05 ws considered to indicte sttisticlly significnt difference. Results LAPTM4B genotypes in ptients with DLBCL. Using PCR nlysis, the present study identified four different LAPTM4B polymorphisms: LAPTM4B*1/1, LAPTM4B*2/2, LAPTM4B*1/2 nd LATPM4B*1/3. As indicted in Fig. 1, 204 bp frgment is encoded by LAPTM4B*1/1, nd 223 bp frgment is encoded by LAPTM4B*2/2. LAPTM4B*1/2 nd LAPTM4B*1/3 re heterozygous. The 204 bp nd 223 bp frgments were both detected in LAPTM4B*1/2. The 204 nd 242 bp frgments were observed in two individuls with LAPTM4B*1/3. The present study detected significnt difference in the distribution of DLBCL between mle nd femle ptients (P<0.002; Tble I). No significnt differences in llele frequency were identified between the DLBCL nd control cses (Tble II). In the 350 controls, the frequency of the LAPTM4B*2 llele ws 24.1%, wheres the frequency in ptients with DLBCL ws 26.5%. The distribution of LAPTM4B genotypes in control nd DLBCL cses re displyed in Tble III. The genotype frequencies for the polymorphism were in greement with the Hrdy Weinberg equilibrium (P=0.898). No significnt differences in the distribution of LAPTM4B*1/2 nd LAPTM4B*2/2 genotypes when compred with LATPM4B*1/1 were detected between the DLBCL nd control cses (P=0.462 nd P=0.368, respectively). The odds rtios of LATPM4B*1/2 nd LATPM4B*2/2 genotypes in ptients with DLBCL compred with ptients with LATPM4B*1/1 is fold (95% CI= ) nd fold (95% CI= ), respectively.
3 266 Figure 1. Schemtic digrm showing LAPTM4B lleles. (A) Sequencing chromtogrms of LAPTM4B lleles. LAPTM4B * 1 contins one copy of the 19 bp sequence. LAPTM4B * 2 contins two tndem repets of the 19 bp sequence, nd LAPTM4B * 3 contins three tndem repets of the 19 bp sequence. (B) LAPTM4B polymorphisms s verified by polymerse chin rection nlysis. Lnes 1 2, LAPTM4B * 1/1; lnes 3 4, LAPTM4B * 1/2; lnes 5 6, LAPTM4B*2/2; lnes 7 8, LAPTM4B * 1/3 genotype. LAPTM4B, lysosoml protein trnsmembrne 4β. Tble I. Distribution of ge nd sex in control nd DLBCL cses. Control cses, DLBCL cses, Chrcteristic n (n=350) n (n=162) P vlue Age > Sex Mle Femle Tble II. Distribution of LAPTM4B lleles in controls (n=350) nd DLBCL cses (n=162). Controls, DLBCL Alleles n (%) cses, n (%) OR (95% CI) LAPTM4B * (75.9) 238 (73.5) LAPTM4B * (24.1) 86 (26.5) ( ) Anlyzed by logistic regression nd nlysis, nd djusted for ge nd sex. CI, confidence intervl; LAPTM4B, lysosoml protein trnsmembrne 4β; DLBCL, diffuse lrge B cell lymphom; OR, Odds rtio. Anlyzed using χ 2 test. DLBCL, diffuse lrge B cell lymphom. LAPTM4B genotypes nd clinicopthologicl prmeters in DLBCL. The present study lso ssessed the distribution of clinicl prmeters, including ge nd sex, mong different LAPTM4B genotypes in ptients with DLBCL (Tble IV). There were no sttisticlly significnt ssocitions between the genotype distribution of LAPTM4B in ptients with DLBCL nd clinicopthologicl prmeters (Tble IV).
4 DING et l: LAPTM4B GENE POLYMORPHISM IN DIFFUSE LARGE B-CELL LYMPHOMA 267 Tble III. Distribution of LAPTM4B genotypes in controls (n=350) nd DLBCL cses (n=162). Genotypes Controls, n (%) DLBC cses, n (%) P vlue OR (95% CI) LAPTM4B * 1/1 199 (56.9) 87 (53.7) LAPTM4B * 1/2 133 (38.0) 64 (39.5) ( ) LAPTM4B * 2/2 18 (5.1) 11 (6.8) ( ) Anlyzed by logistic regression nd nlysis nd djusted for ge nd sex. CI, confidence intervl; LAPTM4B, lysosoml protein trnsmembrne 4β; DLBCL, diffuse lrge B cell lymphom; OR, Odds rtio. Tble IV. Assocition between the distribution of LAPTM4B genotypes nd clinicopthologicl prmeters in DLBCL cses. LAPTM4B genotypes Prmeters *1/1 *1/2 *2/2 P vlue Sex Mle Femle Age > B symptoms b Positive Negtive LDH Positive Negtive β 2 MG Positive Negtive Stge I II III IV Bulky mss 10 cm <10 cm Loclized Yes No No extr nodl c > Incidence site Lymph node Extr lymph IPI score Tble IV. Continued. LAPTM4B genotypes Prmeters *1/1 *1/2 *2/2 P vlue Moleculr subtypes GCB Non GCB Other Anlyzed using χ 2 test or Fisher's exct test. b B symptom includes unexplined fever/chills/weight loss, ftigue nd drenching night swets. c No extr nodl: the number nd type of extr nodl will influence DLBCL ptient prognosis. LAPTM4B, lysosoml protein trnsmembrne 4β; DLBCL, diffuse lrge B cell lymphom; LDH, lctte dehydrogense; MG, mcroglobulin; IPI, Interntionl Prognostic Index; GCB, germinl center B cell. Associtions between LATPM4B genotypes nd prognosis of ptients with DLBCL. In the present study, follow up dt rnging from months (men, 50.5 months) ws obtined for 129 ptients with DLBCL. At the end dte of the follow up, totl of 93 ptients survived nd 36 succumbed to disese. Survivl nlysis ws conducted in the 129 ptients to exmine the effect of LATPM4B polymorphism on the prognosis of ptients with DLBCL. Kpln Meier nlysis nd log rnk test indicted tht LAPTM4B * 2 ws not ssocited with decresed OS nd DFS (P=0.399 nd P=0.520, respectively). However, ptients with the LAPTM4B*2 genotype nd IPI score 3 5 (n=40) tend to exhibit longer durtions of OS nd DFS compred with ptients with the LAPTM4B*1 genotype (P=0.126 nd 0.109, respectively; Fig. 2). Discussion The present study demonstrted tht the presence of the LAPTM4B*2 llele ws not ssocited with mrkedly incresed risk of developing DLBCL compred with LAPTM4B*1. However, in ptients with IPI score 3 5, significntly incresed risk of developing DLBCL ws identified in ptients with the LAPTM4B*2/2 genotype compred with those tht exhibited the LAPTM4B*1/1 genotype. A totl of three tndem repets comprising 19 bp segments were detected in 2/164 of the ptients with DLBCL. Furthermore, ptients with DLBCL tht exhibited LAPTM4B*2 hd tendency to
5 268 Figure 2. Kpln Meier survivl nlysis of ptients with DLBCL with LAPTM4B * 1 nd LAPTM4B * 2 lleles. (A) Kpln Meier survivl curves indicting OS nd DFS in ptients with DLBCL nd LAPTM4B * 1 or LAPTM4B * 2 lleles. OS nd DFS were strtified by IPI scores: (B) 0 2 nd (C) 3 5. LAPTM4B, lysosoml protein trnsmembrne 4β; OS, overll survivl; DFS, disese free survivl; DLBCL, diffuse lrge B cell lymphom; IPI, interntionl prognostic index. hve incresed durtions of OS nd DFS compred with those with LAPTM4B*1, prticulrly those tht lso exhibited IPI score 3 5. To the best of our knowledge, the present study is the first to demonstrte, lbeit not sttisticlly, tht LAPTM4B*2 is more useful prognostic indictor for DLBCL compred with LAPTM4B*1. However, this finding is not consistent with the results of previous studies, including those ssessing heptocellulr crcinom, lung nd brest cncer (17,18,21). LAPTM4B hs two known protein isoforms: LAPTM4B 24 (226 ) nd LAPTM4B 35 (317 ) (22). Previous studies hve indicted tht LAPTM4B 35 is ble to ctivte the binding of phosphoinositide 3 kinse (PI3K)/protein kinse B (Akt) to p85α subunits, nd thereby fcilitte cncer cell multidrug resistnce nd inhibit poptosis (23). Liu et l (22,24) used polyclonl ntibody to demonstrte tht LAPTM4B 35 nd LAPTM4B 24 my differ in expression nd function in tissues nd multiple cell lines of heptocellulr crcinom. The blnce of LAPTM4B 35 nd LAPTM4B 24 my ffect mlignnt trnsformtion. Multiple studies hve reveled tht LAPTM4B 35 my prticipte in mlignnt trnsformtion nd tumor invsion (25 28). However, recent report demonstrted tht the LAPTM4B 24 isoform ws ble to stimulte mechnistic trget of rpmycin complex (mtorc)1 through vcuolr type H + ATPse vi the influx of leucine resulting from the binding of LAT1 4F2hc to lysosomes (29). LAPTM4B 24 my lso promote cell growth nd prolifertion nd regulte immune responses by decresing trnsforming growth fctor β1 production in humn regultory T cells (29,30). Although s forementioned there re two known isoforms of LAPTM4B, the present study suggested tht nother isoform my exist due to the LAPTM4B*2 llele. The 19 bp difference in the first exon of LAPTM4B between LAPTM4B*1
6 DING et l: LAPTM4B GENE POLYMORPHISM IN DIFFUSE LARGE B-CELL LYMPHOMA 269 nd LAPTM4B*2 my lter the open reding frme, thereby resulting in two different protein isoforms: LAPTM4B 35 nd LAPTM4B 40 (8,17). Previous studies hve demonstrted tht LAPTM4B polymorphisms were ssocited with n incresed risk of multiple types of cncer, including ovrin, brest nd gllbldder cncer (13,31,32). These findings suggest tht the 19 bp sequence my serve n importnt function in trnscriptionl regultion, or different protein isoform encoded by LAPTM4B*2 my ffect cncer cell function (8). Yng et l (17) indicted tht LAPTM4B*2 ws ssocited with tumor recurrence nd poor histopthologicl differentition, nd is n independent prognostic fctor in heptocellulr crcinom. Other studies hve reported similr results for lung cncer, nd endometril nd gllbldder crcinom (18,19,32). In the present study, the LAPTM4B*2 llele ws not ssocited with significntly incresed risk of developing DLBCL, nd there ws no significnt ssocition with survivl in ptients with DLBCL. However, there ws tendency for ptients with LAPTM4B*2 to hve improved OS nd DFS compred with ptients with LAPTM4B*1 in DLBCL, nd this pttern ws more evident in cses with IPI score 3 5. The 19 bp sequence my serve crucil role in trnscriptionl regultion, including binding with trnscription fctors, micrornas or non coding linker RNA in ptients with DLBCL, which discrimintes its function with tht of other types of cncer, including heptocellulr crcinom (15,17). Therefore, the different LAPTM4B protein isoforms my hve diverse functions in ptients with LAPTM4B*2 compred with those with LAPTM4B*1 in DLBCL. The results of the present study on LAPTM4B lleles in ptients with DLBCL my provide dditionl evidence tht different LAPTM4B protein isoforms could serve multiple functions. For exmple, it ws previously reported tht LAPTM4B 35 my ctivte the PI3 K/Akt signling pthwy, nd LAPTM4B 24 my ctivte mtorc1 (23,29). Identifying the isoform tht predomintes in the induction of the 19 bp sequence in vrious types of cncer should be investigted in further studies. The present study ssessed the ssocition between LAPTM4B polymorphisms nd prognosis of ptients with DLBCL. It ws indicted tht LAPTM4B*2 my be more useful prognostic indictor for DLBCL compred with LAPTM4B*1, prticulrly in cses with IPI score 3 5 compred with IPI score 0 2 (lthough this trend ws not sttisticlly significnt). IPI is crucil indictor for selecting the pproprite therpeutic strtegies in DLBCL. In DLBCL, ptients with IPI score 0 2 hve good prognosis with the rte of 5 yer survivl reching 80% (33). In the present study, the lck of ssocition between LAPTM4B*2 llele nd survivl of ptients with IPI score 0 2 my be due to the smll number of cses in the present study. However, there is poor rte of 5 yer survivl (<50%) following the stndrd R CHOP tretment in ptients with IPI score 3 5 (33). LAPTM4B*2 llele my be good indictor for ptients with IPI score 3 5 nd my be used to guide clinicl therpy to reduce unnecessry drug tretment. Acknowledgements The present study ws supported by Ntionl Nturl Science Foundtion of Chin (grnt no ) nd the Beijing Nturl Science Foundtion (grnt no ). References 1. Interntionl Agency for Reserch on Cncer: World Cncer Report World-Cncer-Reports/World-Cncer-Report Accessed July, Sehn LH, Donldson J, Chhnbhi M, Fitzgerld C, Gill K, Kls R, McPherson N, O'Reilly S, Spinelli JJ, Sutherlnd J, et l: Introduction of combined CHOP plus rituximb therpy drmticlly improved outcome of diffuse lrge B cell lymphom in British Columbi. J Clin Oncol 23: , Perry AR nd Goldstone AH: High dose therpy for diffuse lrge cell lymphom in first remission. Ann Oncol 9 (Suppl 1): S9 S14, Fisher RL, Gynor ER, Dhlberg S, Oken MM, Grogn TM, Mize EM, Glick JH, Coltmn CA Jr nd Miller TP: Comprison of stndrd regimen (CHOP) with three intensive chemotherpy regimens for dvnced non Hodgkin's lymphom. N Engl J Med 328: , Interntionl Non Hodgkin's Lymphom Prognostic Fctors Project: A predictive model for ggressive non Hodgkin's lymphom. N Engl J Med 329: , Ruzinov MB, Cron T nd Rodig SJ: Altered subcellulr locliztion of c Myc protein identifies ggressive B cell lymphoms hrboring c MYC trnsloction. Am J Surg Pthol 34: , Zhou Z, Sehn LH, Rdemker AW, Gordon LI, Lcsce AS, Crosby Thompson A, Vnderpls A, Zelenetz AD, Abel GA, Rodriguez MA, et l: An enhnced Interntionl Prognostic Index (NCCN IPI) for ptients with diffuse lrge B cell lymphom treted in the rituximb er. Blood 123: , Sho GZ, Zhou RL, Zhng QY, Zhng Y, Liu JJ, Rui JA, Wei X nd Ye DX: Moleculr cloning nd chrcteriztion of LAPTM4B, novel gene unregulted in heptocellulr crcinom. Oncogene 22: , Deng LJ, Zhng QY, Liu B nd Zhou RL: Reltionship between LAPTM4B gene polymorphism nd susceptibility of lung cncer. Beijing D Xue Xue Bo 37: , 2005 (In Chinese). 10. Fn M, Liu Y, Zhou R nd Zhng Q: Assocition of LAPTM4B gene polymorphism with brest cncer susceptibility. Cncer Epidemiol 36: , Liu Y, Zhng QY, Qin N nd Zhou RL: Reltionship between LAPTM4B gene polymorphism nd susceptibility of gstric cncer. Ann Oncol 18: , Cheng XJ, Xu W, Zhng QY nd Zhou RL: Reltionship between LAPTM4B gene polymorphism nd susceptibility of colorectl nd esophgel cncers. Ann Oncol 19: , Xu Y, Liu Y, Zhou R, Meng F, Go Y, Yng S, Li X, Yng M nd Lou G: LAPTM4B polymorphisms is ssocited with ovrin cncer susceptibility nd its prognosis. Jpn J Clin Oncol 42: , Li C, Zhou Q, Wng Y, Chen X, Yng X nd Zhu D: Reltionship between LAPTM4B gene polymorphism nd susceptibility of lung cncer. Zhongguo Fei Ai Z Zhi 9: , 2006 (In Chinese). 15. Wng S, Zhng QY nd Zhou RL: Reltionship between LAPTM4B gene polymorphism nd susceptibility of primry liver cncer. Ann Oncol 23: , Wng B, Xu J, Zhou R nd Zhng Q: Assocition of LAPTM4B gene polymorphism with nsophryngel crcinom susceptibility in Chinese popultion. Med Oncol 30: 470, Yng H, Zhi G, Ji X, Xiong F, Su J nd McNutt MA: LAPTM4B llele *2 is mrker of poor prognosis following heptic tumor resection for heptocellulr crcinom. PLoS One 7: e34984, Tng H, Tin H, Yue W, Li L, Li S, Go C, Si L, Qi L, Lu M nd Hu W: LAPTM4B polymorphism is ssocited with non smll cell lung cncer susceptibility nd prognosis. Oncol Rep 31: , Meng F, Li H, Zhou R, Luo C, Hu Y nd Lou G: LAPTM4B gene polymorphism nd endometril crcinom risk nd prognosis. Biomrkers 18: , Nrynn S nd Svge KJ: Stging nd prognostic fctors. In: Non Hodgkin Lymphoms. Armitge JO, Much PM, Hrris NL, Coiffier B nd Dll Fver R (eds). 2nd edition. Lippincott Willims & Wilkins, Phildelphi, PA, pp , Li X, Kong X, Chen X, Zhng N, Jing L, M T nd Yng Q: LAPTM4B llele *2 is ssocited with brest cncer susceptibility nd prognosis. PLoS One 7: e44916, 2012.
7 Liu XR, Zhou RL, Zhng QY, Zhng Y, Jin YY, Lin M, Rui JA nd Ye DX: Structure nlysis nd expressions of novel tetrtrnsmembrne protein, lysosom ssocited protein trnsmembrne 4 bet ssocited with heptocellulr crcinom. World J Gstroenterol 10: , Li L, Wei XH, Pn YP, Li HC, Yng H, He QH, Png Y, Shn Y, Xiong FX, Sho GZ nd Zhou RL: LAPTM4B: A novel cncer ssocited gene motivtes multidrug resistnce through efflux nd ctivting PI3K/AKT signling. Oncogene 29: , Liu X, Zhou R, Zhng Q, Zhng Y, Sho G, Jin Y, Zhng S, Lin M, Rui J nd Ye D: Identifiction nd chrcteriztion of LAPTM4B encoded by humn heptocellulr crcinom ssocited novel gene. Beijing D Xue Xue Bo 35: , 2003 (In Chinese). 25. He J, Sho G nd Zhou R: Effects of the novel gene, LAPTM4B, highly expression in heptocellulr crcinom on cell prolifertion nd tumorigenesis of NIH3T3 cells. Beijing D Xue Xue Bo 35: , 2003 (In Chinese). 26. Yng H, Xiong F, Wei X, Yng Y, McNutt MA nd Zhou R: Overexpression of LAPTM4B 35 promotes growth nd metstsis of heptocellulr crcinom in vitro nd in vivo. Cncer Lett 294: , Zhou L, He XD, Yu JC, Zhou RL, Shn Y nd Rui JA: Overexpression of LAPTM4B 35 ttenutes epirubucin induced poptosis of gllbldder crcinom GBC SD cells. Surgery 150: 25 31, Sho GZ, Zhou RL, Zhng QY, Zhng Y, Liu JJ, Rui JA, Wei X nd Ye DX: Moleculr cloning nd chrcteriztion of LAPTM4B, novel gene upregulted in heptocellulr crcinom. Oncogene 22: , Milkereit R, Persud A, Vnoic L, Guetg A, Verrey F nd Rotin D: LAPTM4b recruits the LAT1 4F2hc Leu trnsporter to lysosomes nd promotes mtorc1 ctivtion. Nt Commun 6: 7250, Huygens C, Lienrt S, Dedobbeleer O, Stockis J, Guthy E, Coulie PG nd Lucs S: Lysosoml ssocited Trnsmembrne Protein 4B (LAPTM4B) Decreses Trnsforming Growth Fctor β1 (TGF β1) Production in Humn Regultory T Cells. J Biol Chem 290: , Xio M, Ji S, Wng H, Wng J, Hung Y nd Li Z: Overexpression of LAPTM4B: An independent prognostic mrker in brest cncer. J Cncer Res Clin Oncol 139: , Zhi G, Yn K, Ji X, Xu W, Yng J, Xiong F, Su J, McNutt MA nd Yng H: LAPTM4B llele *2 is mrker of poor prognosis for gllbldder crcinom. PLoS One 7: e45290, Sehn LH, Berry B, Chhnbhi M, Fitzgerld C, Gill K, Hoskins P, Kls R, Svge KJ, Shenkier T, Sutherlnd J, et l: The revised interntionl prognostic index (R IPI) is better predictor of outcome thn the stndrd IPI for ptients with diffuse lrge B cell lymphom treted with R CHOP. Blood 109: , 2007.
Efficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationStudy on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric
JBUON 2017; 22(6): 1488-1493 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mil: editoril_office@jbuon.com ORIGINAL ARTICLE Study on the ssocition between PI3K/AKT/mTOR signling pthwy gene polymorphism
More informationEsophageal carcinoma is the eighth most common cancer
ORIGINAL ARTICLE Tumor-Strom Rtio Is n Independent Predictor for Survivl in Esophgel Squmous Cell Crcinom Ki Wng, MD,* Wei M, MD,* Jinbo Wng, MD,* Ling Yu, MD, Xiomei Zhng, MD, Zhenbo Wng, MD, Bingxu Tn,
More informationPrognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with nonmetastatic
Crcinogenesis, 2015, Vol. 36, No. 2, 243 248 doi:10.1093/crcin/bgu247 Advnce Access publiction December 18, 2014 Originl Mnuscript originl mnuscript Prognostic significnce of pretretment serum levels of
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationThe Acute Time Course of Concurrent Activation Potentiation
Mrquette University e-publictions@mrquette Exercise Science Fculty Reserch nd Publictions Exercise Science, Deprtment of 1-1-2010 The Acute Time Course of Concurrent Activtion Potentition Luke Grceu Mrquette
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationRESEARCH ARTICLE. Wen Li 1, Jing Deng 2 *, Shuang-Shuang Wang 1, Liang Ma 1, Jiang Pei 1, Xiao-Xi Zeng 1, Jian-Xin Tang 1. Abstract.
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.24.10937 Methyltion of the RAR-β Gene nd Cigrette Smoking in NSCLC in Southern-Centrl Chinese RESEARCH ARTICLE Assocition of Methyltion of the RAR-β Gene with
More informationOriginal Article Prognostic and clinicopathologic significance of AEG-1/MTDH and E-cadherin expression in human gallbladder carcinoma
Int J Clin Exp Pthol 2018;11(12):6025-6031 www.ijcep.com /ISSN:1936-2625/IJCEP0086349 Originl Article Prognostic nd clinicopthologic significnce of AEG-1/MTDH nd E-cdherin expression in humn gllbldder
More informationImpact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors
Originl Article Impct of Positive Nodl Metstses in Ptients with Thymic Crcinom nd Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, nd Jennifer L. Sullivn, MD Introduction: Thymic crcinoms
More informationCHEST. Thyroid transcription factor 1 (TTF-1) is an important. Original Research
CHEST Originl Reserch Clinicl Significnce of Thyroid Trnscription Fctor-1 in Advnced Lung Adenocrcinom Under Epiderml Growth Fctor Receptor Tyrosine Kinse Inhibitor Tretment Kuei-Pin Chung, MD; Yen-Tsung
More informationSignificance of Expression of TGF- in Pulmonary Metastasis in Non-small Cell Lung Cancer Tissues
Originl Article Significnce of Expression of in Pulmonry Metstsis in Non-smll Cell Lung Cncer Tissues Hisshi Sji, Hruhiko Nkmur, Idiris Awut, Norihito Kwski, Msru Hgiwr, Akihiko Ogt, Mkoto Hosk, Tkmoto
More informationAssociation of PTEN expression with liver function and inflammatory changes in patients with liver cancer after chemotherapy
ONCOLOGY LETTERS Assocition of PTEN expression with liver function nd inflmmtory chnges in ptients with liver cncer fter chemotherpy JIXIANG ZHOU nd XIAOLI LI Deprtment of Heptobiliry Surgery, Xingy Hospitl,
More informationClinical manifestations in patients with alpha-fetoprotein producing gastric cancer
Curr Oncol, Vol. 21, pp. e394-399; doi: http://dx.doi.org/10.3747/co.21.1768 CLINICAL MANIFESTATIONS IN AFP PRODUCING GASTRIC CANCER ORIGINAL ARTICLE Clinicl mnifesttions in ptients with lph-fetoprotein
More informationGenetic polymorphisms in the TERT-CLPTM1L region and lung cancer susceptibility in Chinese males
1588 Genetic polymorphisms in the TERT-CLPTM1L region nd lung cncer susceptibility in Chinese mles XUYANG XIAO 1 nd WUBIN HE 2 1 Deprtment of Thorcic Surgery nd 2 Biologicl Therpy Center Lbortory, The
More informationJournal of Hainan Medical University.
132 Journl of Hinn Medicl University 2017; 23(11): 132-136 Journl of Hinn Medicl University http://www.hnykdxxb.com Assessment of the efficcy nd sfety of bronchil rtery perfusion chemotherpy combined with
More informationOne of the most important biological mechanisms of
Brief Report Serum Thymidine Kinse 1 Activity in the Prognosis nd Monitoring of Chemotherpy in Lung Cncer Ptients: A Brief Report Benjmin Nismn, PhD,* Hovv Nechushtn, MD, PhD,* Him Birn, MD, Hds Gntz-Sorotsky,
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationLung cancer is the leading cause of cancer death worldwide, EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Originl Article EGFR Muttion nd Brin Metstsis in Pulmonry Adenocrcinoms Dong-Yeop Shin, MD,* Im Il N, MD,* Cheol Hyeon Kim, MD, PhD, Sunhoo Prk, MD, PhD, HeeJong Bek, MD, PhD, nd Sung Hyun Yng, MD, PhD*
More informationORIGINAL ARTICLE ABSTRACT INTRODUCTION
ORIGINAL ARTICLE LOSS OF EPCAM STAINING CORRELATES WITH POOR OUTCOME IN CRC, Wng et l. Reduction in membrnous immunohistochemicl stining for the intrcellulr domin of epithelil cell dhesion molecule correltes
More informationEffects of modified FOLFOX-6 chemotherapy on cellular immune function in patients with gastric cancer
ONCOLOGY LETTERS 15: 8635-8640, 2018 Effects of modified FOLFOX-6 chemotherpy on cellulr immune function in ptients with gstric cncer LIANG WANG 1, DONGER ZHOU 1, HAITAO REN 2 nd YAN CHEN 3 Deprtments
More informationOriginal Article Serum tumor markers used for predicting esophagogastric junction adenocarcinoma in esophageal malignancy
Int J Clin Exp Med 2016;9(6):11859-11864 www.ijcem.com /ISSN:1940-5901/IJCEM0025330 Originl Article Serum tumor mrkers used for predicting esophgogstric junction denocrcinom in esophgel mlignncy Yongkng
More informationA118G Polymorphism in l-opioid Receptor Gene and Interactions with Smoking and Drinking on Risk of Oesophageal Squamous Cell Carcinoma
Journl of Clinicl Lbortory Anlysis 31: e22018 (2017) A118G Polymorphism in l-opioid Receptor Gene nd Interctions with Smoking nd Drinking on Risk of Oesophgel Squmous Cell Crcinom Xinfng Xu,* Boneng Mo,
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationRheumatoid-susceptible alleles of HLA-DRB 1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists
Annls of the Rheumtic Diseses 1994; 53: 587-592 587 Deprtment of Orthopedic Surgery, Knsi Medicl University, Otokoym Hospitl, Kyoto, Jpn Y Tod Y Mori Deprtment of Orthopedic Surgery, Knsi Medicl University,
More informationPaper-based skin patch for the diagnostic screening of cystic fibrosis
Electronic Supplementry Mteril (ESI) for ChemComm. This journl is The Royl Society of Chemistry 2015 Supplementry informtion Pper-bsed skin ptch for the dignostic screening of cystic fibrosis Xun Mu,*
More informationFeeding state and age dependent changes in melaninconcentrating hormone expression in the hypothalamus of broiler chickens
Supplementry Mterils Epub: No 2017_23 Vol. 65, 2018 https://doi.org/10.183/bp.2017_23 Regulr pper Feeding stte nd ge dependent chnges in melninconcentrting hormone expression in the hypothlmus of broiler
More informationMOLECULAR AND CLINICAL ONCOLOGY 7: , 2017
MOLECULAR AND CLINICAL ONCOLOGY 7: 787-797, 2017 Evlution of epiderml growth fctor receptor serum levels nd their ssocition with clinicopthologicl chrcteristics in ptients with colorectl cncer MEHMET KARABULUT
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationCopy Number ID2 MYCN ID2 MYCN. Copy Number MYCN DDX1 ID2 KIDINS220 MBOAT2 ID2
Copy Numer Copy Numer Copy Numer Copy Numer DIPG38 DIPG49 ID2 MYCN ID2 MYCN c DIPG01 d DIPG29 ID2 MYCN ID2 MYCN e STNG2 f MYCN DIPG01 Chr. 2 DIPG29 Chr. 1 MYCN DDX1 Chr. 2 ID2 KIDINS220 MBOAT2 ID2 Supplementry
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationAmerican Joint Committee on Cancer Staging and Clinicopathological High-Risk Predictors of Ocular Surface Squamous Neoplasia
Americn Joint Committee on Cncer Stging nd Clinicopthologicl High-Risk Predictors of Oculr Surfce Squmous Neoplsi A Study From Tertiry Eye Center in Indi Sheetl Chuhn, MSc; Seem Sen, MD; Anjn Shrm, PhD;
More informationClinical statistics analysis on the characteristics of pneumoconiosis of Chinese miner population
Originl Article Clinicl sttistics nlysis on the chrcteristics of pneumoconiosis of Chinese miner popultion Mei-Fng Wng 1 *, Run-Ze Li 2 *, Ying Li 2, Xue-Qin Cheng 1, Jun Yng 1, Wen Chen 3, Xing-Xing Fn
More informationOriginal Article CD40-1C>T polymorphism and the risk of lung cancer in a Chinese population
Int J Clin Exp Pthol 2015;8(11):15163-15169 www.ijcep.com /ISSN:1936-2625/IJCEP0015790 Originl Article CD40-1C>T polymorphism nd the risk of lung cncer in Chinese popultion Gng Zhou 1*, Ying Wng 1,2*,
More informationAberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8 + T lymphocytes in human cholangiocarcinoma
ONCOLOGY REPORTS 36: 419-427, 2016 Aberrnt expression of B7-H4 correltes with poor prognosis nd suppresses tumor-infiltrtion of CD8 + T lymphocytes in humn cholngiocrcinom Xin Zho *, Fei Guo *, Zhonghu
More informationAge related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer
MOLECULAR AND CLINICAL ONCOLOGY 9: 329-334, 2018 Age relted differences in prognosis nd prognostic fctors mong ptients with epithelil ovrin cncer KENJI YOSHIKAWA, TAKESHI FUKUDA, RYO UEMURA, HIROAKI MATSUBARA,
More informationAssociation on polymorphisms in LncRNA HOTAIR and susceptibility to HNSCC in Chinese population
Europen Review for Medicl nd Phrmcologicl Sciences 2018; 22: 702-706 Assocition on polymorphisms in LncRNA HOTAIR nd susceptibility to HNSCC in Chinese popultion B. WU 1, J. LIU 2, B. WANG 2, X. LIAO 1,
More informationExpression of circulating microrna-1 and microrna-133 in pediatric patients with tachycardia
MOLECULAR MEDICINE REPORTS 11: 4039-4046, 2015 Expression of circulting microrna-1 nd microrna-133 in peditric ptients with tchycrdi LING SUN 1*, SHUO SUN 2*, SHAOYING ZENG 1, YUFEN LI 1, WEI PAN 1 nd
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationClassic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic Features
The Koren Journl of Pthology 2014; 48: 201-208 ORIGINAL ARTICLE Clssic Ppillry Thyroid Crcinom with Tll Cell Fetures nd Tll Cell Vrint Hve Similr Clinicopthologic Fetures Woo Jin Oh 1 Young Sub Lee 1 Uiju
More informationSerum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes
originl rticle Serum nesftin-1 levels re decresed in pregnnt women newly dignosed with gesttionl dibetes Esr Nur Ademoglu 1, Suheyl Gorr 2, Muge Keskin 3, Ayse Crlioglu 4, Rifki Ucler 5, Husmettin Erdmr
More informationIMpower133: Primary PFS, OS, and safety in a Ph1/3 study of 1L atezolizumab + carboplatin + etoposide in extensive-stage SCLC
IMpower133: Primry PFS, OS, nd sfety in Ph1/3 study of 1L tezolizumb + crbopltin + etoposide in extensive-stge SCLC S. V. Liu, 1 A. S. Mnsfield, 2 A. Szczesn, 3 L. Hvel, 4 M. Krzkowski, 5 M. J. Hochmir,
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationA cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis
Originl Article A cross-sectionl nd follow-up study of leukopeni in tuberculosis ptients: prevlence, risk fctors nd impct of nti-tuberculosis tretment Fei-Shen Lin 1 *, Mei-Ying Wu 2 *, Wen-Jun Tu 3, Hong-Qiu
More informationHuman leukocyte antigen-drb1 polymorphism in childhood acute lymphoblastic leukemia
MOLECULAR AND CLINICAL ONCOLOGY 3: 425-429, 2015 Humn leukocyte ntigen-drb1 polymorphism in childhood cute lymphoblstic leukemi MERVAT M. EL ANSARY 1, LAMIAA A. MOHAMMED 2, TAMER H. HASSAN 3, AHMED BARAKA
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationThe expression of p73 is increased in lung cancer, independent of p53 gene alteration
Article no. bjoc.1999.0572 The expression of p73 is incresed in lung cncer, independent of p53 gene ltertion Y Tokuchi 1, T Hshimoto 1, Y Kobyshi 2, M Hyshi 1, K Nishid 2, S Hyshi 1, K Imi 1, K Nkchi 1,
More informationNeutrophil lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
2454 Neutrophil lymphocyte rtio predicts survivl in pncretic neuroendocrine tumors GUOPEI LUO 1 3*, CHEN LIU 1 3*, HE CHENG 1 3*, KAIZHOU JIN 1 3, MENG GUO 1 3, YU LU 1 3, JIANG LONG 1 3, JIN XU 1 3, QUANXING
More informationCorrelation between CT features and liver function and p53 expression in hepatitis, cirrhosis and hepatocellular carcinoma
ONCOLOGY LETTERS Correltion between CT fetures nd liver function nd p53 expression in heptitis, cirrhosis nd heptocellulr crcinom YAHUI HU, JING WU, SHA LI nd XIAOXIAO ZHAO Deprtment of Nucler Medicine,
More informationONCOLOGY LETTERS 14: , China Medical University, Shenyang, Liaoning , P.R. China
4890 Expression of vsculr endothelil growth fctor nd cspse 3 in mucinous brest crcinom nd infiltrting ductl crcinom not otherwise specified, nd the correltion with disese free survivl QIULI WANG 1, LISHA
More informationEffects of blueberries on migration, invasion, proliferation, the cell cycle and apoptosis in hepatocellular carcinoma cells
BIOMEDICAL REPORTS 5: 579-584, 2016 Effects of blueberries on migrtion, invsion, prolifertion, the cell cycle nd poptosis in heptocellulr crcinom cells WEI ZHAN 1*, XIN LIAO 2*, LEI YU 3, TIAN TIAN 3,
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationRegistre des Tumeurs Digestives du Calvados, CJF INSERM 96-03, Faculté de Médecine, Avenue de Côte de nacre, Caen cedex, France;
British Journl of Cncer (1999) 81(2), 5 9 Article no. bjoc.1999.0692 Colorectl cncer fter negtive Hemoccult II test nd progrmme sensitivity fter first round of screening: the experience of the Deprtment
More informationComparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight
Bone Mrrow Trnsplnttion, (1999) 23, 867 873 1999 Stockton Press All rights reserved 0268 3369/99 $12.00 http://www.stockton-press.co.uk/bmt Comprison of utologous peripherl blood stem cell dosing by idel
More informationRisk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort
Specil Report Risk of Colorectl Cncer by Subsite in Swedish Prostte Cncer Cohort Yunxi Lu, MD, PhD, Rickrd Ljung, MD, PhD, Ann Mrtling, MD, PhD, nd Mts Lindbld, MD, PhD Bckground: The reltionship between
More informationBody mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health
Originl Article - Sexul Dysfunction/Infertility pissn 2005-6737 eissn 2005-6745 Body mss index, wist-to-hip rtio, nd metbolic syndrome s predictors of middle-ged men's helth Jung Hyun Prk *, In-Chng Cho
More informationAnalysis of detection results of thyroid function-related indexes in pregnant women and establishment of the reference interval
EXPERIMENTAL AND THERAPEUTIC MEDICINE Anlysis of detection results of thyroid function-relted indexes in pregnnt women nd estblishment of the reference intervl QI ZHOU 1*, YANLI ZHANG 1*, JIANHUA ZHOU
More informationUsing proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience
ORIGINAL ARTICLE Using prolifertive mrkers nd Oncotype DX in therpeutic decision-mking for brest cncer: the B.C. experience E. Bxter bsc,* L. Gondr btech pdc, C. Lohrisch md, S. Chi md, K. Gelmon md, M.
More informationA genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population
Mutgenesis vol. 28 no. 4 pp. 441 446 Advnce Access puliction 16 My 2013 doi:10.1093/mutge/get023 A genetic vrint in ERCC2 is ssocited with gstric cncer prognosis in Chinese popultion Hiyn Chu 1,2,, Dongying
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationThe effect of encapsulated butyric acid and zinc on performance, gut integrity and meat quality in male broiler chickens 1
The effect of encpsulted utyric cid nd zinc on performnce, gut integrity nd met qulity in mle roiler chickens 1 Astrct This study evluted the impct of encpsulted utyric cid nd zinc (ButiPEARL Z) on performnce
More informationInvasive Pneumococcal Disease Quarterly Report July September 2018
Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.
More informationProphylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications
Gstric Cncer (2018) 21:703 709 https://doi.org/10.1007/s10120-017-0781-y ORIGINAL ARTICLE Prophylctic effect of neodjuvnt chemotherpy in gstric cncer ptients with postopertive complictions Kojiro Eto 1
More informationEfficacy of Sonidegib in Patients With Metastatic BCC (mbcc)
AAD 216 eposter 3368 Efficcy of Sonidegib in Ptients With Metsttic BCC (mbcc) Colin Morton, 1 Michel Migden, 2 Tingting Yi, 3 Mnish Mone, 3 Dlil Sellmi, 3 Reinhrd Dummer 4 1 Stirling Community Hospitl,
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationEffects of physical exercise on working memory and prefrontal cortex function in post-stroke patients
Effects of physicl exercise on working memory nd prefrontl cortex function in post-stroke ptients M Moriy, C Aoki, K Sktni Grdute School of Helth Sciences Reserch, Mjor of Physicl Therpy, TeikyoHeisei
More informationCorrelation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells
ONCOLOGY LETTERS Correltion of ERK/MAPK signling pthwy with prolifertion nd poptosis of colon cncer cells GANG ZHOU, JING YANG nd PENG SONG Deprtment of Medicl Oncology, The Second Medicl Centre, Chinese
More informationAssociation of genetic polymorphisms in DNMT3A with the progression of gastric mucosal atrophy and susceptibility to gastric cancer in Japan
ONCOLOGY LETTERS Assocition of genetic polymorphisms in DNMT3A with the progression of gstric mucosl trophy nd susceptibility to gstric cncer in Jpn WU JING 1, TOSHIMI OTSUKA 1, MASAKATSU NAKAMURA 1, NAOKO
More informationDifferent components of chicken egg-white extracts affect cell cycle and apoptosis. doi: /j.issn
19 46 2151112 Chinese Journl of Tissue Engineering Reserch November 12, 215 Vol.19, No.46 ( 6532 6532 6532) S ku 3 ku S (214BAI1B1)(213CA5) S 293T ku ku 3 ku 3 ku 3 d ku 3 ku S ku 3 ku S. [J]. 21519(46):7451-7455.
More informationphosphatase isoenzyme activity: estimation of
J Clin Pthol 1988;41:202-206 Quntittive method for determining serum lkline phosphtse isoenzyme ctivity: estimtion of intestinl component M J PEAKE, M PEJAKOVIC, G H WHITE From the Deprtment ofbiochemistry
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationSingle-Molecule Studies of Unlabelled Full-Length p53 Protein Binding to DNA
Single-Molecule Studies of Unlbelled Full-Length p53 Protein Binding to DNA Philipp Nuttll, 1 Kidn Lee, 2 Pietro Ciccrell, 3 Mrco Crminti, 3 Giorgio Ferrri, 3 Ki- Bum Kim, 2 Tim Albrecht 1* 1 Imperil College
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationAnalysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia
284 Anlysis of lterntives for izing ptients to chieve glycemic control nd void ccompnying risks of hypoglycemi JIALIN GAO 1,2*, QIANYIN XIONG 1,2*, JUN MIAO 1*, YAO ZHANG 2,3, LIBING XIA 1, MEIQIN LU 1,
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationA retrospective, single center cohort study on 65 patients with primary retroperitoneal liposarcoma
ONCOLOGY LETTERS 15: 1799-1810, 2018 A retrospective, single center cohort study on 65 ptients with primry retroperitonel liposrcom YI XI WU 1, JUN YAN LIU 1*, JIA JIA LIU 1*, PENG YAN 1, BO TANG 1, YOU
More informationEvaluation of the TEST 1 erythrocyte sedimentation rate system and intra- and inter-laboratory quality control using new latex control materials
Clin Chem Lb Med 2010;48(7):1043 1048 2010 by Wlter de Gruyter Berlin New York. DOI 10.1515/CCLM.2010.162 Evlution of the TEST 1 erythrocyte sedimenttion rte system nd intr- nd inter-lbortory qulity control
More informationExpression of long chain fatty acid receptor GPR40 is associated with cancer progression in colorectal cancer: A retrospective study
ONCOLOGY LETTERS 15: 8641-8646, 2018 Expression of long chin ftty cid receptor GPR40 is ssocited with cncer progression in colorectl cncer: A retrospective study CHIE NAKASHIMA 1, KISHI SHINGO 1, RINA
More informationRelation of Tumor Size, Lymph Node Status, and Survival in
Reltion of Tumor Size, Lymph Node Sttus, nd Survivl in 24,74 Brest Cncer Cses CHRISTINE L. CARTER, PHD, MPH,* CAROL ALLEN, PHD,t AND DONALD E. HENSON, MD* Two of the most importnt prognostic indictors
More informationARTICLE. E. Pavlova 1, N. Atanassova 1, C. McKinnell 2, R.M. Sharpe 2 1 Institute of Experimental Morphology, Pathology and Anthropology with Museum,
DOI:.554/5YRTIMB..3 OPPOSITE MODELS OF EXPRESSION OF ANDROGEN RECEPTOR (AR) AND RETINOIC ACID RECEPTOR-α (RAR-α) IN THE ONSET OF MALE GERM CELL DEVELOPMENT IN HORMONALLY MANIPULATED RATS E. Pvlov, N. Atnssov,
More informationAdjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice
doi: 10.1054/ bjoc.2001.2035, vilble online t http://www.idelibrry.com on http://www.bjcncer.com Adjuvnt chemotherpy for colon crcinom with positive lymph nodes: use nd benefit in routine helth cre prctice
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationAnalysis of Regulatory of Interrelated Activity of Hepatocyte and Hepatitis B Viruses
Interntionl Journl of Biomedicl Mterils Reserch 8 6(): -7 http://www.sciencepublishinggroup.com/j/ijbmr doi:.648/j.ijbmr.86. ISSN: 33-756 (Print) ISSN: 33-7579 (Online) Anlysis of Regultory of Interrelted
More informationMICRO RNA-21 EXPRESSION LEVELS IN INVASIVE BREAST CARCINOMA WITH A NON-INVASIVE COMPONENT
Arch. Biol. Sci., Belgrde, 67(4), 1285-1295, 2015 DOI:10.2298/ABS150327105P MICRO RNA-21 EXPRESSION LEVELS IN INVASIVE BREAST CARCINOMA WITH A NON-INVASIVE COMPONENT Nin Petrović 1,*, Snežn Jovnović-Ćupić
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationMETHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY
METHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY 1.0 SCOPE AND APPLICATION 1.1 Method 4010 is procedure for screening solids such s soils, sludges, nd queous medi such s wste wter nd lechtes
More informationPrognostic factors in tongue cancer relative importance of demographic, clinical and histopathological factors
British Journl of Cncer (2000) 83(5), 614 619 doi: 10.1054/ bjoc.2000.1323, vilble online t http://www.idelibrry.com on Prognostic fctors in tongue cncer reltive importnce of demogrphic, clinicl nd histopthologicl
More informationHigh EGFR mrna expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
INTERNATIONAL JOURNAL OF ONCOLOGY 38: 629-641, 2011 High EGFR mrna expression is prognostic fctor for reduced survivl in pncretic cncer fter gemcitbine-bsed djuvnt chemotherpy Hyto Fujit 1, Kenoki Ohuchid
More informationClinical significance of zinc finger E box binding homeobox 1 mrna levels in peritoneal washing for gastric cancer
MOLECULAR AND CLINICAL ONCOLOGY 3: 435-441, 2015 Clinicl significnce of zinc finger E box binding homeobox 1 mrna levels in peritonel wshing for gstric cncer NORIMITSU YABUSAKI, SUGURU YAMADA, TOSHIFUMI
More informationTranscription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines
P.O.Box 2345, Beijing 100023,Chin World J Gstroenterol 2002;8(2):203-207 Fx: +86-10-85381893 World Journl of Gstroenterology E-mil: wcjd@public.bt.net.cn Copyright 2002 by The WJG Press ISSN 1007-9327
More informationEvaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
1332 Evlution of the detection of 14 high-risk humn ppillomviruses with HPV 16 nd HPV 18 genotyping for cervicl cncer screening MEI-LU BIAN, JIAO-YING CHENG, LI MA, XIAO CONG, JUN LIU, YING CHEN nd XI
More informationA Comparison of Serum Magnesium Level in Pregnant Women with and without Gestational Diabetes Mellitus (GDM)
Brief Report J Bbol Univ Med Sci Vol 18, Issu 12; Dec 2016. P:71-75 A Comprison of Serum Mgnesium Level in Pregnnt Women with nd without Gesttionl Dibetes Mellitus (GDM) Z. Bouzri (MD) 1, F. Elmi(MD) 2,
More informationUtilization of dental services in Southern China. Lo, ECM; Lin, HC; Wang, ZJ; Wong, MCM; Schwarz, E
Title Utiliztion of dentl services in Southern Chin Author(s) Lo, ECM; Lin, HC; Wng, ZJ; Wong, MCM; Schwrz, E Cittion Journl Of Dentl Reserch, 2001, v. 80 n. 5, p. 1471-1474 Issued Dte 2001 URL http://hdl.hndle.net/10722/53200
More informationOsteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes
ONCOLOGY LETTERS Osteosrcom in ptients below 25 yers of ge: An observtionl study of incidence, metstsis, tretment nd outcomes ZHIGANG NIE nd HAO PENG Deprtment of Orthopedics, Renmin Hospitl of Wuhn University,
More informationPD L1 expression is associated with advanced non small cell lung cancer
ONCOLOGY LETTERS 12: 921-927, 2016 PD L1 expression is ssocited with dvnced non smll cell lung cncer ZHIQUAN CHEN 1 3, JIANDONG MEI 3 5, LUNXU LIU 4,5, GUOCHEN WANG 2, ZUOSHENG LI 2, JINGPU HOU 2, QIUYANG
More informationDA XU *, XIAOFENG LIU *, LIJUN WANG and BAOCAI XING
ONCOLOGY LETTERS Heptectomy plus djuvnt trnsctheter rteril chemoemboliztion improves the survivl rte of ptients with multicentric occurrence of heptocellulr crcinom DA XU *, XIAOFENG LIU *, LIJUN WANG
More informationRelationship between serum irisin, glycemic indices, and renal function in type 2 diabetic patients
J Renl Inj Prev. 2017; 6(2): 88-92. http://journlrip.com Journl of Renl Injury Prevention DOI: 10.15171/jrip.2017.17 Reltionship between serum irisin, glycemic indices, nd renl function in type 2 dibetic
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationBarrier to autointegration factor 1: A novel biomarker for gastric cancer
ONCOLOGY LETTERS Brrier to utointegrtion fctor 1: A novel biomrker for gstric cncer JUNJUN LI 1, BINGBING HU 2, LEI FANG 3, YANG GAO 1, SHUAI SHI 3, HAOYU HE 1, XIAOMEI LIU 1 nd CAIJUN YUAN 1 1 Deprtment
More information